The Latest Cardiac and Vascular News
Email Print Friendly Share July 25, 2019 16:01 ET | Source: Merit Medical Systems, Inc. Q2 2019 worldwide revenue of $255.5 million, up 13.7% as reported over Q2 2018 Q2 2019 core revenue on a comparable, constant currency basis* up 9.6% over Q2 2018 Q2 2019 GAAP EPS was $0.12, compared to $0.21 in Q2 […]
AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with conventional PCI for the treatment of anterior STEMI patients. The first patient enrolled into this study was treated at Oxford Heart Center, Oxford, […]
SAN CARLOS, Calif., July 25, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced it has signed an extension to a 2017 development agreement with AstraZeneca [NYSE:AZN] for BioCardia’s Helix™ biotherapeutic delivery catheter system. Under the terms of the initial pre-clinical […]
San Francisco, July 25, 2019 (GLOBE NEWSWIRE) — Eko, a Silicon Valley-based digital health company applying machine learning in the fight against heart disease, today announced Eko Home, a first-of-its-kind service that enables precise remote monitoring of cardiac function using ECG and heart sounds. Eko Home can be used to create […]
MOUNTAIN VIEW, Calif., July 24, 2019 /PRNewswire/ — AliveCor, the leader in FDA-cleared consumer electrocardiogram technology, today announced the appointment of Priya Abani as Chief Executive Officer. Abani comes to the company with decades of experience creating scale in digital platform technologies. Most recently, Abani was the General Manager for Devices and Enablement at […]
VANCOUVER, July 25, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for Brinavess™ (vernakalant hydrochloride, IV), an antiarrhythmic drug for the rapid conversion […]
Newly Approved Minimally Invasive Therapy Treats Diseased Veins Using Proprietary Medical Adhesive Mumbai, Maharashtra, India: India Medtronic Private Limited, wholly owned subsidiary of Medtronic plc (NYSE: MDT), today announced the launch of the VenaSeal™ Closure System, which is a minimally invasive procedure that uses a proprietary medical adhesive to close the diseased vein […]
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the appointment of Michael Favet as Chief Executive Officer. Frank Fischer, after 20 years serving as CEO, continues with NeuroPace as Chairman of the Board of Directors. Mr. Favet has served on the NeuroPace board since 2016, […]
An in silico clinical trial is underway with the 3DEXPERIENCE platform to evaluate the Living Heart simulated 3D heart for transforming how new devices can be tested Five-year extension of their collaborative research agreement aims to spur medical device innovation by enabling innovative, new product designs Both Dassault Systèmes and […]
DENVER–(BUSINESS WIRE)–HeartHero announces the closing of its oversubscribed Series A funding round. This funding secures a pathway for Elliot, an industry disruptive Automated External Defibrillator (AED), to be submitted for FDA Class III approval and CE mark. This round provides resources for high-volume manufacturing and launches HeartHero’s unique go-to-market strategy for […]
